As of close of business last night, Compugen Ltd’s stock clocked out at $2.55, down -13.56% from its previous closing price of $2.95. In other words, the price has decreased by -$0.4000 from its previous closing price. On the day, 2795912 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
To gain a deeper understanding of CGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On May 13, 2020, Stifel started tracking the stock assigning a Buy rating and target price of $19.Stifel initiated its Buy rating on May 13, 2020, with a $19 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEN now has a Market Capitalization of 225.15M and an Enterprise Value of 169.06M. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.03 while its Price-to-Book (P/B) ratio in mrq is 4.23. Its current Enterprise Value per Revenue stands at 22.54 whereas that against EBITDA is -5.16.
Stock Price History:
Over the past 52 weeks, CGEN has reached a high of $2.99, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 2.1336, while the 200-Day Moving Average is calculated to be 1.2623.
Shares Statistics:
It appears that CGEN traded 2.86M shares on average per day over the past three months and 758.16k shares per day over the past ten days. A total of 86.62M shares are outstanding, with a floating share count of 83.51M. Insiders hold about 5.45% of the company’s shares, while institutions hold 13.79% stake in the company. Shares short for CGEN as of Feb 15, 2024 were 2.02M with a Short Ratio of 0.71, compared to 1.6M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.29% and a Short% of Float of 2.29%.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.22 for the current quarter, with a high estimate of $0.57 and a low estimate of -$0.12, while EPS last year was -$0.04. The consensus estimate for the next quarter is $0.07, with high estimates of $0.07 and low estimates of $0.07.
Analysts are recommending an EPS of between $0.25 and -$0.45 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is -$0.04, with 3 analysts recommending between $0.26 and -$0.28.
